GenMark Diagnostics to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.
GenMark’s management team is scheduled to present at the Canaccord 40th Annual Growth Conference on Wednesday, August 12th, 2020 at 3:00pm ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.
GenMark’s management team will also be participating in one-on-one meetings at the 5th Annual Needham Med Tech and Diagnostics 1x1 Conference on Monday,August 17, 2020. Due to the format of this event no webcast will be available.
About GenMark Diagnostics
Investor Relations Contact